INS and Glucose intolerance: Decreased GRK2 levels in global GRK2+/− mice prevent the development of an insulin resistant and obese phenotype in terms of body weight gain, glucose intolerance, and insulin insensitivity in skeletal muscle and liver, thus maintaining glucose homeostasis [13,14,15] and favoring energy expenditure [16].